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Summary
BACKGROUND: Regular follow-up care is essential for
childhood cancer survivors, but we know little about physi-
cians’ experience with it. We aimed to describe: (1) in-
volvement of Swiss physicians in follow-up care; (2) con-
tent of follow-up care provided; (3) problems encountered;
and (4) additional resources needed.
: MATERIALS AND METHODS: Within this cross-section-
al survey we sent adapted questionnaires via professional
associations to a sample of medical oncologists (MOs),
paediatric oncologists (POs), general practitioners (GPs)
and paediatricians (P) in Switzerland. Only oncologists in-
volved in follow-up care were asked to report problems.
GPs and Ps not involved in follow-up could indicate why.
All physicians were asked about the content of follow-up
care provided and additional resources needed.
RESULTS: A total of 183 physicians responded (27 MO,
13 PO, 122 GP, 21 P). Involved in follow-up were 81% of
MOs, 85% of POs, 39% of GPs and 81% of Ps. Follow-
up content differed between oncologists (MO and PO)
and generalists (GP and P), with generalists examining
or informing less in regard to the former cancer. POs
reported more problems than MOs: many POs reported
problems with transition of survivors to adult care (91%),
and because of financial resources (73%) and time re-
straints (73%). MOs reported most problems during tran-
sition (23%). Not being aware of a survivor was the most
common reason for GPs and Ps not participating in follow-
up (74%). All groups reported a need for standardised pro-
tocols (85–91%) and specialised training (55–73%). GPs
(94%) and Ps (100%) additionally desired more support
from oncologists.
CONCLUSIONS: To improve quality and efficiency of fol-
low-up care a national follow-up care model including
standardised protocols and guidelines needs to be devel-
oped.
Key words: childhood cancer survivors, adolescent and
young adult cancer survivors, follow-up care, physicians,
general practitioners, questionnaire survey
Introduction
Childhood cancer survivors are former patients who were
diagnosed with cancer before the age of 15 years and have
survived at least 5 years after diagnosis [1]. An adolescent
and young adult (AYA) cancer survivor is defined as a for-
mer patient diagnosed between 15 and 39 years of age who
survived at least 5 years after diagnosis [1].
High-quality, standardised follow-up care (regular medical
check-ups to identify and treat late adverse outcomes early,
and advice on health behaviour) of childhood and AYA
cancer survivors will be a public health concern for two
main reasons. First, there is an increasing population of
childhood and AYA cancer survivors thanks to improve-
ments of treatment in past decades [2]. The population of
childhood cancer survivors was estimated to be 379 112
in the United States in 2010 [3] and 4902 in Switzerland
in 2015 (including only Swiss residents diagnosed at age
0–14 years) [4]. Second, these survivors are at increased
risk for developing late effects of the cancer and the treat-
ments received [5, 6]. A recent study estimated that 95.5%
of childhood cancer survivors suffered from any chronic
health condition and 80.5% from a serious or life-threaten-
ing chronic condition by the age of 45 years [7].
Because of this increasing population with special medical
needs, many international groups advocate systematic,
risk-stratified and evidence-based long-term follow-up
care for childhood and AYA cancer survivors, and specific
recommendations have been published [8–12]. This is im-
portant to prevent, or detect early, cancer recurrence, sec-
ond malignancies and other health and psychosocial prob-
lems due to the cancer or its treatment [1]. However, sys-
tematic implementation of these recommendations is still
lacking in most countries, including Switzerland, and loss
to follow-up of survivors remains a major problem
[13–16].
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In developed countries, about 1 in 500 young adults be-
tween the age of 20 and 39 years is estimated to be a child-
hood cancer survivor [2, 3, 17]. It is therefore essential that
at some stage, not only specialists such as paediatric and
medical oncologists, but also primary care physicians such
as paediatricians and general practitioners (GPs), are in-
volved in the follow-up care of childhood and AYA can-
cer patients [3, 18–20]. This will help to reduce the finan-
cial burden and preserve specialists’ valuable time for care
of acute cancer patients. To develop such efficient mod-
els of follow-up care including specialists and generalists,
the experience and needs of involved stakeholders (physi-
cians, survivors, parents of survivors) need to be assessed.
Whereas the view of survivors and parents has been in-
vestigated in the past [21–29], we still know little about
the perception of physicians and their involvement in fol-
low-up care [30]. Only three studies involved healthcare
professionals’ view and only one of these included GPs
[31–33]. The studies suggested greater nurse and primary
care involvement, risk-stratified follow-up care, transition
to adult care, increase in psychosocial support and mod-
el-based follow-up care as future directions to be pursued
[30].
We therefore investigated: (1) the involvement of physi-
cians from different specialities in follow-up care of child-
hood and AYA cancer survivors; (2) the content of the
follow-up care they provide; (3) the problems they encoun-
tered; and (4) additional resources they would need to pro-
vide optimal care.
Materials and methods
The Childhood Cancer Follow-Up Study (CCFU)
The CCFU is a nested project of the population-based
Swiss Childhood Cancer Survivor Study (SCCSS), which
had the overall aim of investigating the long-term effects
of childhood cancer and its treatment [34]. The CCFU is
a questionnaire survey with the specific aim of gaining in-
depth knowledge on preferences and needs for the organ-
isation of follow-up care of childhood cancer survivors in
Switzerland [35]. For this purpose, relevant stakeholders
(survivors, survivors’ parents, physicians) were contacted
with questionnaires. This paper evaluates the questionnaire
to physicians sent between 2011 and 2012.
Sample and procedure
We included four groups of physicians frequently involved
in follow-up care in Switzerland: medical oncologists, pae-
diatric oncologists, GPs and paediatricians. Medical on-
cologists and paediatric oncologists were considered spe-
cialists (oncologists), GPs and paediatricians generalists
(primary care physicians). We developed adapted, semi-
structured questionnaires for each group (see appendix 1
for a translated version of all the questions used in the cur-
rent study, provided in separate download file). The ques-
tionnaire to the generalists was short and included 17 ques-
tions; the questionnaire to the specialists had additional
more detailed questions on follow-up care, ending up with
32 items.
We used different strategies to contact the physicians de-
pending on the availability of and access to databases of
physicians in the respective specialty and individual con-
tact information. Medical oncologists received an e-mail
with the study invitation and a link to an online survey
from the Swiss Society of Medical Oncology (n = 241).
From the Swiss Paediatric Oncology Group we received
a list with all paediatric oncologists in Switzerland (n =
40). They were contacted from the study centre by e-mail
with the study invitation and a link to the online survey.
To contact GPs and paediatricians, we used an address
list of all members of the Hausärzte Schweiz: Berufsver-
band der Haus- und Kinderärztinnen Schweiz (Swiss Pro-
fessional Association of General Practitioners and Pae-
diatricians), which unites the Swiss Society of General
Practitioners (SGAM), the Swiss Society of General In-
ternal Medicine (SGIM) and the Swiss Society of Pae-
diatrics (SSP). We received 6312 addresses and drew a
random sample of 700 German- and 300 French-speaking
physicians (reflecting the proportion of the Swiss and Ger-
man speaking population of Switzerland), using the STA-
TA (version 13.1; College Station, TX) command to draw
random samples without replacement. In addition, we con-
tacted the GPs (n = 114) of survivors who provided the
name and address of their doctor (and consent to contact
them) in an earlier questionnaire of the Swiss Childhood
Cancer Survivor Study [34]. The GPs and paediatricians
were contacted by mail and sent a paper-based question-
naire. They could also complete the questionnaire online if
preferred.
Questions on follow-up care
We assessed the following information to describe physi-
cians’ (1) involvement in, (2) content of, (3) problems
with, and (4) needs for optimal follow-up care of, child-
hood and AYA cancer survivors (appendix 1). First, we
asked all physicians to report any experience with child-
hood (diagnosed at age ≤15years) and AYA (diagnosed at
age 16–25years) cancer patients and whether they were
involved in follow-up care. Second, we asked all physi-
cians who were involved in follow-up care, which types
of cancer they follow up and what services they routinely
provide in their follow-up care. Third, to assess problems
in the provision of follow-up care, we asked generalists
who were not involved in follow-up to indicate the reasons
why; we asked oncologists who were involved in follow-
up to report the problems they encountered on the patient
level and on the institution level. Fourth, we asked all
physicians who were involved in follow-up, what addition-
al resources they would need to provide optimal care.
Other information assessed
We assessed physicians’ age at the time of the study, time
since specialisation, sex, work situation (hospital; private
practice; both) and work setting (urban; rural).
Statistical analyses
Statistical analysis was performed with STATA version
13.1. We performed complete case analysis. We used
means and range or numbers and proportions to describe
the study population, overall and stratified by speciali-
sation (medical oncologists, paediatric oncologists, GPs,
paediatricians). To address aim 1, we used numbers and
proportions to describe the involvement of physicians in
follow-up care of childhood and AYA cancer survivors,
overall and stratified by specialisation. We calculated p-
values comparing all four specialisations using univariable
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logistic regression (if the variable of interest was binary)
or univariable multinomial logistic regression (if the vari-
able of interest had more than two categories). Chi-square
statistics were used for comparisons within specialists and
generalists. For aim 2, we used numbers and proportions to
describe the content of follow-up care stratified by special-
isation. Chi-square statistics were used to compare the con-
tent of follow-up care between the medical specialisations.
For aims 3 and 4, we used numbers, proportions and 95%
confidence intervals to describe the problems encountered,
reasons for not engaging in follow-up care and additional
resources needed for optimal care, all stratified by medical
specialisation.
Results
Study Population
Out of the 1395 physicians contacted, 183 (13%) respond-
ed. Of those 183, 27 (15%) were medical oncologists, 13
(7%) paediatric oncologists, 122 (67%) GPs and 21 (12%)
paediatricians (table 1). The mean age of the physicians
at the time of the study was 54.3 years (range 33–81),
mean time since specialisation 20.1 years (range 1–52),
and 76% were male. The working situation differed be-
tween specialisations (p <0.001), with all paediatric oncol-
ogists and half of the medical oncologists working exclu-
sively in a hospital, whereas the generalists mainly worked
in private practices. The work setting also differed (p =
0.010), with oncologists working almost exclusively in ur-
ban areas (92% of medical oncologists and 100% of paedi-
atric oncologists), compared with 69% GPs and 85% pae-
diatricians.
Involvement in follow-up care
Overall, 22 (82%) medical oncologists, 11 (85%) paedi-
atric oncologists, 48 (39%) GPs, and 17 (81%) paediatri-
cians had been involved in follow-up care of young cancer
survivors (table 1). Among specialists, 4 (15%) medical
oncologists and 11 (85%) paediatric oncologists were in-
volved in follow-up care of childhood cancer survivors
(p<0.001; table 2). Twenty-two (82%) medical oncologists
and 10 (77%) paediatric oncologists were involved in fol-
low-up of AYA cancer survivors (p = 0.736). Among gen-
eralists, 16 (13%) GPs and 8 (38%) paediatricians were
currently involved in follow-up care of childhood cancer
survivors (p = 0.005), and 21 (17%) and 1 (5%) in follow-
up of AYA cancer survivors (p = 0.144).
Content of follow-up care
The types of cancers included in follow-up care differed
between the specialisations (all p-values comparing the
prevalence of each diagnosis between the medical spe-
cialisations ≤0.002, fig. 1). Most medical oncologists fol-
lowed up survivors of lymphoma (n = 20, 95% of 22
medical oncologists involved in follow-up). Paediatric on-
cologists followed up survivors of all types of cancer, ex-
cept breast cancer. Most GPs reported following up sur-
vivors of leukaemia (n = 27, 56% of 48 GPs), lymphoma
(n = 17, 35%) and germ cell tumours (n = 16, 33%). Paedi-
atricians mostly saw survivors of leukaemia (n = 15, 88%
of 17 paediatricians) and germ cell tumours (n = 14, 82%)
for follow-up care.
In general, oncologists, independent of whether medical or
paediatric, offered follow-up care of similar content (all p-
values >0.300; fig. 2). The content of follow-up provid-
ed by GPs and paediatricians was also comparable (5 out
of 8 p-values >0.05). However, follow-up care provided
by oncologists differed significantly from the care provid-
ed by generalists (all p <0.05, except for information on
health behaviours). Compared with generalists, more on-
cologists examined survivors for relapse, second tumours
and late somatic effects, and informed them about their
former disease, former treatment and possible late effects.
Differences were less pronounced for the examination of
psychological late effects; counselling on healthy behav-
iour did not differ between oncologists and generalists.
Table 1: Characteristics of physicians who participated in the study.
Total
(n = 183)
Medical oncologists
(n = 27)
Paediatric oncolo-
gists
(n = 13)
General practitioners*
(n = 122)
Paediatricians
(n = 21)
Mean Range Mean Range Mean Range Mean Range Mean Range
p-value
Age at study (years) 54.3 33–81 53.7 39–69 50.2 40–81 54.8 33–74 54.6 43–68 0.339†
Time since specialisation (years) 20.1 1–52 18.8 5–31 15.7 4–52 20.7 1–44 20.8 7–37 0.345†
n %‡ n %‡ n %‡ %‡ n %‡
Sex
Male 139 76.0 21 77.8 9 69.2 95 77.9 14 66.7
Female 44 24.0 6 22.2 4 30.8 27 22.1 7 33.3 0.658§
Work situation
Hospital 30 16.9 15 55.6 13 100 2 1.7 0 0
Own or group practice 135 75.8 4 14.8 0 0 113 96.6 18 85.7
Both 13 7.3 8 29.6 0 0 2 1.7 3 14.3 <0.001¶
Work location
Urban 128 22.9 24 92.3 12 100 75 69.4 17 85.0
Rural 38 77.1 2 7.7 0 0 33 30.6 3 15.0 0.010§
Involved in FU care of child/AYA
cancer survivors‖
Yes 98 53.6 22 81.5 11 84.6 48 39.3 17 81.0
No 85 46.4 5 18.5 2 15.4 74 60.7 4 19.0 <0.001§
AYA = adolescent and young adult; FU = follow-up * general practitioners including general internists (n = 41) and other specialists (n = 10) † p-value from univariable linear
regression models ‡ column percentages are given based on available number for each variable § p-value from univariable logistic regression models ¶ p-value from univariable
mutinomial logistic regression models ‖ survivors of a cancer diagnosed ≤25 years of age
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Table 2: Physicians’ experience with childhood, adolescent and young adult cancer patients and their follow-up care.
Medical oncolo-
gists
(n = 27)
Paediatric oncolo-
gists
(n = 13)
General practition-
ers
(n = 122)
Paediatricians
(n = 21)
n %* n %* n %* n %*
p-value†
Experience with cancer patients in general (only oncologists)‡ n.a.‡ n.a.‡ n.a.‡ n.a.‡
Inpatient treatment of new patients 19 70.3 12 92.3 0.219
Outpatient treatment of new patients 24 88.8 11 84.6 0.217
FU care ≤5 years since diagnosis 22 81.5 12 92.3 0.681
FU care 5-10 years since diagnosis 22 81.5 12 92.3 0.681
Long-term follow-up care ≥10 years since diagnosis 16 59.3 10 76.9 0.416
Other experience with cancer patients 2 7.4 3 23.1 0.192
Experience with follow up care of cancer patients (only oncologists)‡ n.a.‡ n.a.‡ n.a.‡ n.a.‡
FU care childhood cancer 4 14.8 11 84.6 <0.001
FU care AYA cancer 22 81.5 10 76.9 0.736
FU care adult cancer 24 88.9 4 30.8 <0.001
No experience 3 11.5 2 15.4 0.735
Experience with childhood/AYA cancer (only generalists)‡ n.a.‡ n.a.‡ n.a.‡ n.a.‡
Ever diagnosed a childhood/AYA cancer patient 33 27.1 15 71.4 <0.001
Involved in FU care >2 years ago 33 27.1 14 66.7 <0.001
Currently involved in FU care of childhood cancer 16 13.1 8 38.1 0.005
Currently involved in FU care of AYA cancer 21 17.2 1 4.8 0.144
Other experience with childhood/AYA cancer 18 14.8 5 23.8 0.297
No experience with childhood/AYA cancer 75 61.5 1 4.8 <0.001
AYA = adolescents and young adults; FU = follow up; n.a. = not applicable. * more than one answer was possible, the proportion who answered with “yes” in each question is
given † p-value calculated from chi-square statistics ‡ different questions were asked based on the specialisation of the physicians (appendix 1)
Figure 1: Types of cancer in follow-up care of different medical specialists.The values in the figure bars and values in the bars represent the
number of physicians (N) who provide follow-up care to persons who suffered from each type of cancer, stratified by medical specialisation.
The p-values from chi-square statistics for each type of cancer, comparing the four medical specialists, were p <0.001 for leukaemias, lym-
phomas, central nervous system (CNS) tumours, bone tumours, germ cell tumours, breast cancers, Langerhans cell histiocytosis, and p =
0.002 for soft tissue sarcomas.
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Problems encountered and reasons for not engaging in
follow-up care
Generalists could indicate reasons for not engaging in fol-
low-up care (total n = 78; fig. S1 in appendix 2). Most stat-
ed that they were not aware of survivors needing follow up
(n = 58, 74% of 78). Other reasons were that paediatric (n
= 40, 51%) or medical (n = 39, 50%) oncologists were tak-
ing care of these patients; or not having enough experience
to provide follow-up care (n = 22, 28%).
Oncologists who were involved in follow-up care were
asked to indicate problems they encountered (fig. 3). Over-
all, more paediatric than medical oncologists reported
problems. The most frequent problem for paediatric oncol-
ogists (n = 11) on the patient level was that survivors did
not understand the need for follow-up (73%, n = 8). On the
institution level they reported problems with transitioning
patients to adult care (91%, n = 10), lack of time and finan-
cial resources (both 73%, n = 8), and lack of specialised
nurses (64%, n = 7). Medical oncologists (n = 22) report-
ed, on the patient level, that childhood cancer survivors of-
ten wish not to transfer to adult oncologists (23%, n = 5),
and found the distance between home and clinic too long
(18%, n = 4). On the institution level, they reported prob-
lems with transitioning patients (23%, n = 5) and lack of
specialised nurses (18%, n = 4).
Additional resources needed for optimal care
In all four groups of specialisation, most physicians report-
ed that they desired standardised protocols and guidelines
(85–91% variation between groups; fig. 4), followed by the
need for specific training (55–73%). Paediatric oncologists
additionally wished for more financial resources (91%).
GPs and paediatricians would appreciate support from the
treating oncologist (94% of GPs and 100% of paediatri-
cians) and a referral report from the oncologist (98% GPs
and 100% paediatricians).
Discussion
We found that, among our responders, most medical and
paediatric oncologists, as well as paediatricians, have been
involved in follow-up care of young cancer survivors, but
less than half of GPs reported doing so. The types of cancer
diagnoses seen, as well as the content of follow-up care
provided, differed between oncologists and generalists. All
physicians, independent of their specialisation stated the
need for standardised protocols and guidelines (85-91%).
GPs and paediatricians also desired more support from the
treating oncologists (94 and 100%, respectively) and a re-
ferral report with the medical history and recommenda-
tions for follow up (98 and 100%, respectively).
A major strength of our study is that we assessed the opin-
ion of different medical specialists at the same time and
with similar questions (some adaptions between specialisa-
tions were necessary). This allowed us to compare direct-
ly the experiences, problems and needs of different med-
ical specialists regarding follow up of childhood and AYA
cancer survivors. We put a lot of effort into different mail-
ing strategies in order to contact all members or a random
sample of the respective medical speciality. This was rather
difficult in Switzerland, because no national registry with
all active physicians exists. The questionnaire focussed ex-
plicitly on follow-up care, therefore many in-depth ques-
tions could be asked.
This study also has limitations. Because we had no access
to a database of active physicians with contact information,
we had to send most of our questionnaires via professional
associations. We therefore do not know how many physi-
cians really received our questionnaire and we were not
able to send reminders to increase response, which makes
it difficult to judge the representativeness of our sample.
In our study, physicians involved in follow-up might have
been more interested in responding to the questionnaire.
Therefore, our results might not reflect the true participa-
Figure 2: Content of follow-up care provided by different medical specialists.The figure bars represent the proportion of physicians who pro-
vide the respective service within follow-up care, stratified by medical specialisation. The numbers below the bars indicate p-values from chi-
square statistics comparing medical specialists: medical oncologists vs paediatric oncologists; general practitioners vs paediatricians; and both
oncologist combined vs both generalist combined.Light colour = “yes, all patients”; medium colour = “yes, if necessary”; dark colour = “no”GP
= general practitioners; LE = late effects; MO = medical oncologists; PO = paediatric oncologists; P = paediatricians; psychol. = psychological
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tion of Swiss physicians in follow-up care of childhood
and AYA cancer survivors. Because we have no informa-
tion on nonresponders we cannot tell how selection bias
might have affected the results. However, most of our re-
sults focus on physicians who are involved in follow-up
care, and we think that these results are less prone to selec-
tion bias. Also, the different contact strategies might have
affected the response behaviour: physicians might be more
Figure 3: Problems with follow-up care reported by medical and paediatric oncologists.The bars and values at the end of the bars represent
the proportion (%) of physicians who confirmed to have the respective problem, with 95% confidence intervals (indicated by the horizontal
lines).Light blue = paediatric oncologists (n = 11); dark blue = medical oncologists (n = 22)CC = childhood cancer; FU = follow up
Figure 4: Additional resources desired by physicians to provide optimal follow-up care, stratified by medical specialisation.The results are
stratified by type of medical specialisation. The bars and values at the top of the bars represent the proportion (%) of physicians who con-
firmed to desire the respective resource, with 95% confidence intervals. *The corresponding question was put only to medical and paediatric
oncologists. **The corresponding question was put only to general practitioners and paediatricians.Dark blue = medical oncologists (n = 22);
light blue = paediatric oncologists (n = 11); Pink = general practitioners (n = 48); orange = paediatricians (n = 17)
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reluctant to answer a general e-mail from the medical as-
sociation than a personally addressed letter. However, re-
search on selection and response bias has shown that a low
response rate does not necessarily introduce response bias
[36, 37]. In a methodological study, Groves and colleagues
explained this phenomenon by the fact that every person is
potentially either a responder or a nonresponder, depend-
ing on various characteristics and circumstances, and non-
response bias may cancel out across subgroups [36, 37].
Finally, because we stratified our results by specialisation
and because Switzerland is a small country, we ended up
with small numbers of oncologists.
Follow-up care of the growing population of childhood
cancer survivors will become a public health concern [2,
3, 5, 7]. It is therefore important to provide high-quality
and cost-effective care for this population with increased
medical needs [38–41]. A model of care including not only
specialists but also primary care physicians might prevent
over- or undertreatment of survivors and thereby reduce
loss to follow up [42–44]. Our results showed that GPs and
paediatricians are involved in follow-up care of childhood
and AYA cancer survivors. For optimal care, however, they
need standardised protocols and guidelines, support from
the treating oncologist and a referral letter including the
medical history of the patient and recommendations for
follow-up. Similar results were found by Nathan and col-
leagues, where 85% of the contacted US and Canadian
family physicians desired support of the oncologist or fol-
low-up guidelines [45]. Also, Blaauwbroek and colleagues
reported that GPs from the northern Netherlands were will-
ing to participate in follow-up care of childhood cancer
survivors if adequate guidelines and medical information
were provided, and communication lines between the pae-
diatric oncologists and GPs were clear [46].
This need for support and guidelines might reflect uncer-
tainty of generalists about care for childhood cancer sur-
vivors. In our study, 28% of generalists stated that they did
not provide follow-up care owing to lack of experience.
Other studies reported the same lack of knowledge among
primary care physicians regarding health problems of sur-
vivors, optimal surveillance and provision of information
[33, 45]. A recent study found that, among a random sam-
ple of specialists for internal medicine, most reported be-
ing uncomfortable with the care of childhood cancer sur-
vivors and unfamiliar with available guidelines [47]. This
lack of knowledge among GPs and paediatricians might be
reflected in our study in the content of follow-up care they
provided, which differed from the services of oncologists.
GPs and paediatricians examined mostly general physical
and mental health and informed patients about health be-
haviours rather than cancer-specific issues.
To overcome these problems, we have various suggestions
that could be implemented in Switzerland or other coun-
tries with a similar healthcare system in order to develop
a shared-care model including oncologists and generalists.
Generalists need to be educated and provided with guide-
lines sufficiently to feel comfortable in examining and dis-
cussing cancer-related issues. This was tried in a pilot pro-
ject and proved effective in terms of feasibility and interest
of primary care physicians [43]. One specialised primary
care physician for a certain catchment area might be able
to provide adequate follow-up care for all survivors in the
area and involve other specialists if needed.
Furthermore each survivor should receive a personal sur-
vivorship care plan, a so called “survivorship passport”
[48]. This personalised passport contains important infor-
mation about the cancer-specific diagnoses, treatments and
follow-up care recommendations [49, 50]. The specified
follow-up tasks can then be adopted by either specialists
or primary care physicians based on their competencies.
Thanks to the survivorship passport, the tasks can be ef-
ficiently organised and loss to follow-up, as well as
overtreatment, of survivors can be reduced. The passport
is advocated by Childhood Cancer Switzerland, PanCare
(Pan-European Network for Care of Survivors after Child-
hood and Adolescent Cancer) and ENCCA (European Net-
work for Cancer Research in Children and Adolescents)
and is planned to be introduced in Swiss hospitals in au-
tumn 2017 [49, 50].
Conclusion
In Switzerland, many physicians, except GPs, reported be-
ing involved in follow-up of childhood and adolescent can-
cer survivors. To improve quality and efficiency of follow-
up, care a national model including standardised protocols
and guidelines needs to be developed in accordance with
international efforts to standardise follow-up care.
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Appendix 1
Translated English version of the questions
This appendix is provided as a separate file for download-
ing at: https://smw.ch/en/article/doi/smw.2017.14457/
Appendix 2
Supplemental figure
Figure S1: Reasons for not engaging in follow-up care (general practitioners and paediatricians).The bars represent the proportion of physi-
cians (%), with 95% confidence intervals; the values in the bars represent the number of physicians who confirmed the respective reason.AYA
= adolescent and young adult; CC = childhood cancer; FU = follow-up
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